Wu-Wei Lai

Associate Professor

  • 1770 Citations
  • 26 h-Index
1990 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1984, The degree of China Medical University

Research Interests

  • Lung - cancer

Experience

  • 1993/08~2001/07 Lecturer, National Cheng Kung University
  • 2002~present Associate professor, Deparment of Surgery, College of Medicine, National Cheng Kung University

Fingerprint Dive into the research topics where Wu-Wei Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 49 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Caustics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences
Malignant Pleural Effusion Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Taiwan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2018

Research Output 1990 2019

AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression

Liao, S. Y., Kuo, I. Y., Chen, Y. T., Liao, P-C., Liu, Y. F., Wu, H. Y., Lai, W-W. & Wang, Y. C., 2019 Jan 1, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

Protein Stability
Lung Neoplasms
Phosphorylation
Cyclin D1
Chromatin Immunoprecipitation
9 Citations (Scopus)

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Lin, C. Y., Hwang, J. S., Wang, W. C., Lai, W-W., Su, W-C., Wu, T. Y., Yao, G. & Wang, J-D., 2019 Jan 1, In : Journal of the Formosan Medical Association. 118, 1P2, p. 215-222 8 p.

Research output: Contribution to journalArticle

Taiwan
Psychometrics
Statistical Factor Analysis
Survivors
Neoplasms

Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

Su, P. L., Yang, S-C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W-Y., Tseng, Y-L., Lai, W-W., Ho, C-L., Lin, C-C. & Su, W. C., 2019 Jan 1, (Accepted/In press) In : Cancer medicine.

Research output: Contribution to journalArticle

Open Access
DNA
Neoplasms
Mutation
Disease-Free Survival
Therapeutics
2 Citations (Scopus)
Open Access
Esophageal Neoplasms
DNA Repair
DNA Damage
Repair
Down-Regulation
Percutaneous Coronary Intervention
Chronic Obstructive Pulmonary Disease
Cohort Studies
Mortality
Hospital Mortality